ZTOX CATEGORY

IOL CHEMICALS & PHARMACEUTICALS

3 months ago

IOL Chemicals & Pharmaceuticals (IOLCP): Analysts/Institutional Investor Meet/Con. Call Updates

Analysts/Institutional Investor Meet/Con. Call Updates IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about Transcript IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about Transcript

Continue Reading
3 months ago

IOL Chemicals & Pharmaceuticals Releases Transcript of Analyst Meet on NSE

IOL Chemicals and Pharmaceuticals Limited has informed the NSE about the availability of a transcript from its recent analyst and institutional investor meet.

Continue Reading
3 months ago

IOL Chemicals & Pharmaceuticals Submits Transcript to NSE Following Analyst Meet

IOL Chemicals & Pharmaceuticals Limited has submitted a transcript of its recent analyst or institutional investor meet to the NSE, keeping market participants informed about the discussion.

Continue Reading
3 months ago

IOL Chemicals & Pharma Discloses Analyst Meet Transcript on NSE

IOL Chemicals and Pharmaceuticals has informed the NSE about a transcript from an analysts or institutional investor meet, expanding disclosure practices for stakeholder awareness.

Continue Reading
3 months ago

IOL Chemicals & Pharmaceuticals Files Transcript of Analyst Meeting with NSE

IOL Chemicals and Pharmaceuticals Limited has submitted a transcript of its recent analyst and institutional investor meet to the National Stock Exchange, as per an NSE filing.

Continue Reading
3 months ago

IOL Chemicals Releases Investor Meet Transcript on NSE

IOL Chemicals and Pharmaceuticals Limited has submitted a transcript disclosure to NSE following an analyst and institutional investor meet, keeping market participants informed about the company's investor communications.

Continue Reading
3 months ago

IOL Chemicals & Pharmaceuticals Releases Analyst Meeting Transcript

IOL Chemicals & Pharmaceuticals has informed the exchange about releasing a transcript from an analyst or institutional investor meeting, offering retail investors access to institutional perspectives.

Continue Reading
3 months ago

IOL Chemicals Releases Transcript of Analyst Meet

IOL Chemicals and Pharmaceuticals Limited has notified the NSE about the availability of a transcript from its recent analyst or institutional investor interaction.

Continue Reading
3 months ago

IOL Chemicals & Pharmaceuticals Discloses Investor Meet Transcript on NSE

IOL Chemicals & Pharmaceuticals Limited has informed NSE about the availability of a transcript from its recent analyst and institutional investor meet, enabling greater transparency for market participants.

Continue Reading
3 months ago

IOL Chemicals Q3 FY25 Preview: What Analysts Expect

IOL Chemicals & Pharmaceuticals (IOLCP) corporate announcement on BSE signals Q3 FY25 earnings update. Analysts review prior quarter performance and anticipate key metrics.

Continue Reading
3 months ago

IOL Chemicals & Pharmaceuticals Announces Earnings Call Update

IOL Chemicals & Pharmaceuticals (IOLCP) released its earnings call transcript via BSE, offering stakeholders insight into the company's quarterly performance and strategic outlook.

Continue Reading
3 months ago

IOL Chemicals & Pharmaceuticals Q2 Earnings Call Transcript Available on BSE

IOL Chemicals & Pharmaceuticals has published its quarterly earnings call transcript on BSE. The announcement provides investors access to management commentary on company performance and strategy.

Continue Reading

Live Updates

Quick Notification

AI Insights

Smart analysis of market trends

Smart Alerts

Notifications on crucial events

WhatsApp & Telegram

Alerts in the chat you already use

FREE PLAN · PAID UPGRADES FROM ₹89/MO

Track Indian stocks with ZTOX AI

NSE & BSE filings, earnings, insider trades, and smart volume alerts — on WhatsApp or Telegram. No separate app to install.

Free 5 companies
Basic 20 companies
Pro Up to 500 companies
A

"ZTOX has transformed how I track companies. The real-time alerts and AI insights save me hours of research every day."

— Aditya M., Active Trader